The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective study of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104).
 
Ikuo Takahashi
No Relationships to Disclose
 
Mototugu Shimokawa
No Relationships to Disclose
 
Yasunori Emi
Honoraria - Chugai Pharma
 
Hiroaki Tanioka
No Relationships to Disclose
 
Takeshi Shiraishi
No Relationships to Disclose
 
Eiji Oki
Honoraria - Chugai Pharma
 
Hiroshi Saeki
No Relationships to Disclose
 
Akihito Tsuji
Honoraria - Chugai Pharma
 
Sumiya Ishigami
No Relationships to Disclose
 
Yoshihiro Kakeji
Honoraria - Chugai Pharma
 
Hideo Baba
No Relationships to Disclose
 
Shoji Natsugoe
No Relationships to Disclose
 
Yoshihiko Maehara
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma